Watch the agents work

safe: approve — High urgency and negative 3‑month relative strength with no price buffer; short holding period makes downside risk outweigh short‑term tax cost. | neutral: defer — Holding period is 1 day (STCG 20% tax) and churn cost (~0.25%+tax) outweighs marginal signal; urgency is high but conviction low and no invalidation trigger yet, so defer until composite falls below 80 for three sessions or price breaches 50‑day EMA. | risky: defer — Only 1‑day holding, low conviction (2) and short‑term gain would incur 20% tax plus ~0.25% churn cost; RS already negative but composite still high – better to wait for a clearer exit signal before realizing a short‑term loss/gain.

safe: defer — Pharma/Healthcare already holds three positions; adding another would increase sector concentration and churn cost, so defer pending sector‑cap review. | neutral: veto — Pharma/Healthcare already has three holdings (IPCALAB, LAURUSLABS, NEULANDLAB); adding a fourth would overly concentrate the portfolio in this theme, breaching sector‑concentration guidelines under the cautious regime. | risky: approve — Pharma sector strong, composite 96.8 with +5.3 delta, RS positive, price above EMAs; although this would be the third pharma holding, it stays within reasonable sector exposure and meets high conviction.

safe: approve — Logistics sector currently unrepresented; strong composite, positive RS and no concentration risk make the trade acceptable despite churn and tax friction. | neutral: approve — Logistics sector is under‑represented, signal is strong (high composite, positive RS, price above EMA‑150/200), no risk flags and churn cost is justified; fits within sector caps and cautious regime. | risky: approve — Logistics sector rank strong, composite 96 with +12.25 delta, RS 0.149 positive, price above EMAs, no existing logistics exposure – aligns with high conviction and adds diversification.

safe: approve — Defence sector will be cleared by APOLLO exit, so adding PARAS restores exposure without breaching sector caps; strong composite and RS justify entry. | neutral: approve — Strong defence sector rank, high composite and RS, price above EMA‑150/200, no risk flags; adds a second defence position which is within typical sector limits and aligns with cautious regime. | risky: approve — Defence sector rank strong, composite 97 with +11.25 5‑day delta, RS 0.5 strong, price above EMA‑50/200, no risk flags; adds a second defence holding (still within sector concentration) and matches high conviction.